Actualizado 18/04/2008 14:08
- Comunicado -

Herceptin(R) Helps Eradicate HER2-Positive Breast Tumours When Given Before Surgery (y 2)

(2) Gianni L, et al., Neoadjuvant trastuzumab in locally advanced breast cancer (NOAH):antitumor and safety analysis. Abstract # 532. American Society of Clinical Oncology Annual Meeting 2007

(3) Rastogi et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008 Feb 10;26(5):778-85

(4) Kaufmann, von Minckwitz. Preoperative (neoadjuvant) systemic treatment of breast cancer. Breast. 2005 Dec;14(6):576-81

(5) Harries M, Smith I. The development and clinical use of trastuzumab (Herceptin). Endocr Relat Cancer 9: 75-85, 2002

(6) World Health Organization, http://www.who.int/cancer/detection/brea...

(7) Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No.5, Version 2.0. IARCPress, Lyon, 2004

For further information please contact: Corinne Fründt, F. Hoffmann-La Roche Ltd, Mobile: +41-(0)79-5937216, corinne.fruendt@roche.com. Patricia Dessert, Ketchum, Mobile : +44-(0)7980-313-147, patricia.dessert@ketchum.com

Contenido patrocinado